E. Norriton, Penn., March 26, 2019
TGaS® Advisors, a division of Trinity, announced that Tracy L. Mills was promoted to vice president, Executive Commercial Operations (ECOS) practice, for the benchmarking and advisory services firm. She joins a senior ECOS management team, helping companies optimize consolidation, integration, transformation and other major initiatives across the commercial sector and leverage the benefits of high-level benchmarking. Mills previously worked with the company’s Emerging Life Sciences Network (elsN), where she provided consulting and advisory services for more than a dozen emerging biotech and pharmaceutical member clients and helped identify new business opportunities.
Before coming to TGaS, Mills worked with global biopharmaceutical, diagnostic and device manufacturers and client service providers, ranging from start-up to Fortune 100. She served as vice president, Client Services, for Symbiotix, an innovative medical education and communications firm, and senior director, Commercial Operations and Planning, for Intercept Pharmaceuticals, a company that develops and commercializes novel therapeutics for non-viral liver diseases. She began her career at Ortho Pharmaceutical, holding positions in sales, sales training and product marketing. Tracy spent 12 years at Merck & Co., Inc., progressing through positions in product marketing, medical strategies and sales force effectiveness.
TGaS President Gary McWalters said, “Tracy is the ideal person to join the ECOS leadership team to help this practice continue to grow. She has tremendous industry experience and has excelled in her role at elsN.”
Mills earned a BA in Sociology, Anthropology and Spanish at Earlham College in Richmond, Indiana, and an MS in Organizational Dynamics at the University of Pennsylvania. Certifications include Connor Change Management and Six Sigma Champion. She is a member of the Healthcare Businesswomen’s Association (HBA) and the Association for Talent Development (ATD).